UNC119B

gene
On this page

Also known as MGC5139POC7B

Summary

UNC119B (unc-119 lipid binding chaperone B, HGNC:16488) is a protein-coding gene on chromosome 12q24.31, encoding Protein unc-119 homolog B (A6NIH7). Myristoyl-binding protein that acts as a cargo adapter: specifically binds the myristoyl moiety of a subset of N-terminally myristoylated proteins and is required for their localization.

Enables lipid binding activity. Involved in cilium assembly and lipoprotein transport. Located in ciliary transition zone.

Source: NCBI Gene 84747 — RefSeq curated summary.

At a glance

  • GWAS associations: 12
  • Clinical variants (ClinVar): 48 total
  • MANE Select transcript: NM_001080533

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16488
Approved symbolUNC119B
Nameunc-119 lipid binding chaperone B
Location12q24.31
Locus typegene with protein product
StatusApproved
AliasesMGC5139, POC7B
Ensembl geneENSG00000175970
Ensembl biotypeprotein_coding
OMIM620513
Entrez84747

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 4 nonsense_mediated_decay, 3 protein_coding, 1 retained_intron

ENST00000344651, ENST00000539658, ENST00000618898, ENST00000718081, ENST00000718082, ENST00000718083, ENST00000718084, ENST00000953441

RefSeq mRNA: 1 — MANE Select: NM_001080533 NM_001080533

CCDS: CCDS31914

Canonical transcript exons

ENST00000344651 — 5 exons

ExonStartEnd
ENSE00001369996120716628120716739
ENSE00001383176120716870120717042
ENSE00002249997120710458120710718
ENSE00003692746120713274120713387
ENSE00004034067120719920120723640

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 93.38.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 30.4529 / max 197.7089, expressed in 1815 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
12838029.20731814
1283811.2456910

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ventricular zoneUBERON:000305393.38gold quality
right uterine tubeUBERON:000130293.02gold quality
islet of LangerhansUBERON:000000692.45gold quality
right adrenal glandUBERON:000123392.36gold quality
left adrenal glandUBERON:000123492.08gold quality
right adrenal gland cortexUBERON:003582791.91gold quality
left adrenal gland cortexUBERON:003582591.69gold quality
fallopian tubeUBERON:000388991.37gold quality
adrenal glandUBERON:000236990.91gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099190.70gold quality
adult mammalian kidneyUBERON:000008290.17gold quality
pituitary glandUBERON:000000789.71gold quality
adenohypophysisUBERON:000219689.71gold quality
olfactory segment of nasal mucosaUBERON:000538689.07gold quality
right lobe of thyroid glandUBERON:000111989.01gold quality
left lobe of thyroid glandUBERON:000112088.80gold quality
thyroid glandUBERON:000204688.65gold quality
ganglionic eminenceUBERON:000402388.63gold quality
kidneyUBERON:000211388.62gold quality
ovaryUBERON:000099288.61gold quality
left ovaryUBERON:000211988.49gold quality
pancreasUBERON:000126488.47gold quality
stromal cell of endometriumCL:000225588.28gold quality
metanephros cortexUBERON:001053388.01gold quality
smooth muscle tissueUBERON:000113587.87gold quality
body of uterusUBERON:000985387.83gold quality
cortex of kidneyUBERON:000122587.70gold quality
right ovaryUBERON:000211887.62gold quality
myometriumUBERON:000129687.47gold quality
hypothalamusUBERON:000189887.32gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.86
E-MTAB-2983no473.72
E-MTAB-6379no59.83

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

129 targeting UNC119B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-4476100.0068.182030
HSA-MIR-6876-5P100.0067.682126
HSA-MIR-118499.9968.191458
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-103A-3P99.9869.141595
HSA-MIR-10799.9869.141595
HSA-MIR-314899.9775.066478
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-4725-3P99.9669.532520
HSA-MIR-6780B-5P99.9669.602562
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-391099.9571.132227
HSA-MIR-6845-3P99.9466.881439
HSA-MIR-1-3P99.9372.351914
HSA-MIR-20699.9372.501893
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-22-3P99.9368.13917
HSA-MIR-145-5P99.9271.131836
HSA-MIR-5195-3P99.9270.921877
HSA-MIR-497-5P99.9271.832674
HSA-MIR-61399.9171.501710
HSA-MIR-129799.9173.413162

Literature-anchored findings (GeneRIF, showing 1)

  • Integrated analysis of histone lysine lactylation (Kla)-specific genes suggests that NR6A1, OSBP2 and UNC119B are novel therapeutic targets for hepatocellular carcinoma. (PMID:37903971)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriounc119bENSDARG00000009629
mus_musculusUnc119bENSMUSG00000046562
rattus_norvegicusMlecENSRNOG00000021725
drosophila_melanogasterunc-119FBGN0025549
caenorhabditis_elegansWBGENE00006843

Paralogs (1): UNC119 (ENSG00000109103)

Protein

Protein identifiers

Protein unc-119 homolog BA6NIH7 (reviewed: A6NIH7)

All UniProt accessions (1): A6NIH7

UniProt curated annotations — full annotation on UniProt →

Function. Myristoyl-binding protein that acts as a cargo adapter: specifically binds the myristoyl moiety of a subset of N-terminally myristoylated proteins and is required for their localization. Binds myristoylated NPHP3 and plays a key role in localization of NPHP3 to the primary cilium membrane. Does not bind all myristoylated proteins. Probably plays a role in trafficking proteins in photoreceptor cells.

Subunit / interactions. Found in a complex with ARL3, RP2 and UNC119B; RP2 induces hydrolysis of GTP ARL3 in the complex, leading to the release of UNC119B. Interacts with NPHP3 (when myristoylated). Interacts with CYS1 (when myristoylated). Interacts with MACIR; interaction only takes place when UNC119B is not liganded with myristoylated proteins.

Subcellular location. Cell projection. Cilium.

Domain organisation. Adopts an immunoglobulin-like beta-sandwich fold forming a hydrophobic cavity that capture N-terminally myristoylated target peptides. Phe residues within the hydrophobic beta sandwich are required for myristate binding.

Similarity. Belongs to the PDE6D/unc-119 family.

RefSeq proteins (1): NP_001074002* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR008015PDED_domDomain
IPR014756Ig_E-setHomologous_superfamily
IPR037036PDED_dom_sfHomologous_superfamily
IPR051519PDE6D_unc-119_myristoyl-bdFamily

Pfam: PF05351

UniProt features (23 total): strand 9, helix 4, mutagenesis site 3, modified residue 2, initiator methionine 1, chain 1, turn 1, region of interest 1, binding site 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
7OK6X-RAY DIFFRACTION1.95
7OK7X-RAY DIFFRACTION3.15

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A6NIH7-F181.770.71

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (1): 142

Post-translational modifications (2): 2, 24

Mutagenesis-validated functional residues (3):

PositionPhenotype
144reduced binding to myristoylated proteins; when associated with a-148 and a-207.
148reduced binding to myristoylated proteins; when associated with a-144 and a-207.
207reduced binding to myristoylated proteins; when associated with a-144 and a-148.

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-5624138Trafficking of myristoylated proteins to the cilium

MSigDB gene sets: 198 (showing top): GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, AMIT_EGF_RESPONSE_480_MCF10A, MODULE_379, GOBP_CILIUM_ORGANIZATION, GOBP_ORGANELLE_ASSEMBLY, GOBP_LIPOPROTEIN_LOCALIZATION, FUJII_YBX1_TARGETS_DN, CAIRO_HEPATOBLASTOMA_UP, GOBP_CELL_PROJECTION_ORGANIZATION, MODULE_242, MCCLUNG_COCAIN_REWARD_4WK, MODULE_104, GOCC_MOTILE_CILIUM

GO Biological Process (5): nervous system development (GO:0007399), lipoprotein transport (GO:0042953), cilium assembly (GO:0060271), protein transport (GO:0015031), cell projection organization (GO:0030030)

GO Molecular Function (2): lipid binding (GO:0008289), protein binding (GO:0005515)

GO Cellular Component (4): cytosol (GO:0005829), cilium (GO:0005929), ciliary transition zone (GO:0035869), cell projection (GO:0042995)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Cargo trafficking to the periciliary membrane1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
binding2
system development1
protein transport1
lipoprotein localization1
axoneme assembly1
intraciliary transport involved in cilium assembly1
cilium organization1
protein localization to cilium1
organelle assembly1
trans-Golgi to periciliary membrane compartment transport1
plasma membrane bounded cell projection assembly1
ciliary transition zone assembly1
transport1
intracellular protein localization1
establishment of protein localization1
cellular component organization1
cytoplasm1
intraciliary transport particle1
membrane-bounded organelle1
plasma membrane bounded cell projection1
cilium1

Protein interactions and networks

STRING

1825 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
UNC119BARL3P36405758
UNC119BNPHP3Q7Z494745
UNC119BPDE6DO43924633
UNC119BGNAT1P11488620
UNC119BCYS1Q717R9552
UNC119BCCDC71Q8IV32549
UNC119BARL2P36404548
UNC119BURB2Q14146450
UNC119BARL13BQ3SXY8447
UNC119BSRCP12931436
UNC119BCFAP36Q96G28435
UNC119BFAM114A1Q8IWE2433
UNC119BDNAAF19Q8IW40388
UNC119BGRB2P29354373
UNC119BN4BP3O15049325

IntAct

53 interactions, top by confidence:

ABTypeScore
ARL3UNC119Bpsi-mi:“MI:0914”(association)0.730
UNC119UNC119Bpsi-mi:“MI:0914”(association)0.640
NPHP3UNC119Bpsi-mi:“MI:0914”(association)0.590
UNC119BNPHP3psi-mi:“MI:0407”(direct interaction)0.590
PSKH2UNC119Bpsi-mi:“MI:0914”(association)0.530
AVPI1UNC119Bpsi-mi:“MI:0914”(association)0.530
PALD1UNC119Bpsi-mi:“MI:0914”(association)0.530
LZTS2UNC119Bpsi-mi:“MI:0914”(association)0.530
STK16UNC119Bpsi-mi:“MI:0914”(association)0.530
GNAT1UNC119Bpsi-mi:“MI:0407”(direct interaction)0.440
ZFC3H1UNC119Bpsi-mi:“MI:0914”(association)0.350
PAPD5UNC119Bpsi-mi:“MI:0914”(association)0.350
ARL3psi-mi:“MI:0914”(association)0.350
NPHP3ARHGEF35psi-mi:“MI:0914”(association)0.350
RNF34UNC119Bpsi-mi:“MI:0914”(association)0.350
RNASELUNC119Bpsi-mi:“MI:0914”(association)0.350
SLA2RPSA2psi-mi:“MI:0914”(association)0.350

BioGRID (52): UNC119B (Affinity Capture-RNA), UNC119B (Affinity Capture-RNA), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Affinity Capture-MS), UNC119B (Proximity Label-MS), UNC119B (Affinity Capture-MS)

ESM2 similar proteins: A0A1D6HQ92, A2WSZ6, A2XX39, A2ZVY5, A6NIH7, B4FR29, B9Q0C2, F4IVL6, O60291, P04294, P04413, P49727, P68350, Q05A36, Q07820, Q0J7T6, Q0JAI1, Q2QNS6, Q2QPW2, Q3UE17, Q42840, Q53JI9, Q53K52, Q58CZ0, Q5R4R7, Q5VM82, Q5VRL3, Q6IMP4, Q6L5G1, Q6UDF4, Q6UDI9, Q6UDL6, Q6ZBS8, Q750B5, Q75CM4, Q7XDY9, Q7XLY8, Q7YRZ9, Q80TL4, Q84MH1

Diamond homologs: A6NIH7, O19177, Q10658, Q13432, Q17297, Q3SYR2, Q62885, Q66JA9, Q6INE2, Q8C4B4, Q90Z08, Q9XYQ2, Q9Z2R6, O55057, Q95142, Q9XT54, O43924

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

48 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance44
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

767 predictions. Top by Δscore:

VariantEffectΔscore
12:120710715:GAGA:Gdonor_gain1.0000
12:120710716:AGA:Adonor_gain1.0000
12:120710717:GA:Gdonor_gain1.0000
12:120710717:GAG:Gdonor_gain1.0000
12:120710719:G:GGdonor_gain1.0000
12:120713265:T:TAacceptor_gain1.0000
12:120713269:TTCA:Tacceptor_loss1.0000
12:120713270:TCAG:Tacceptor_loss1.0000
12:120713272:A:AGacceptor_gain1.0000
12:120713272:A:Cacceptor_loss1.0000
12:120713273:G:GCacceptor_gain1.0000
12:120713273:GA:Gacceptor_gain1.0000
12:120713273:GAT:Gacceptor_gain1.0000
12:120713273:GATT:Gacceptor_gain1.0000
12:120713273:GATTA:Gacceptor_gain1.0000
12:120713350:G:Tdonor_gain1.0000
12:120713385:CAG:Cdonor_loss1.0000
12:120713386:AGG:Adonor_loss1.0000
12:120713387:GGTA:Gdonor_loss1.0000
12:120713388:G:Tdonor_loss1.0000
12:120713389:T:Gdonor_loss1.0000
12:120716623:TTCA:Tacceptor_loss1.0000
12:120716626:A:AGacceptor_gain1.0000
12:120716627:G:Aacceptor_loss1.0000
12:120716627:G:GAacceptor_gain1.0000
12:120716627:GA:Gacceptor_gain1.0000
12:120716627:GAC:Gacceptor_gain1.0000
12:120716627:GACC:Gacceptor_gain1.0000
12:120716733:GGGC:Gdonor_gain1.0000
12:120716734:GGC:Gdonor_gain1.0000

AlphaMissense

1651 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:120710692:T:AV73D1.000
12:120713280:T:CL84S1.000
12:120713283:G:AC85Y1.000
12:120713284:T:GC85W1.000
12:120713299:C:AN90K1.000
12:120713299:C:GN90K1.000
12:120713310:T:AI94N1.000
12:120713315:T:CF96L1.000
12:120713315:T:GF96V1.000
12:120713316:T:CF96S1.000
12:120713316:T:GF96C1.000
12:120713317:C:AF96L1.000
12:120713317:C:GF96L1.000
12:120713322:G:CR98P1.000
12:120713324:T:AF99I1.000
12:120713324:T:CF99L1.000
12:120713324:T:GF99V1.000
12:120713325:T:CF99S1.000
12:120713325:T:GF99C1.000
12:120713326:C:AF99L1.000
12:120713326:C:GF99L1.000
12:120713331:T:AI101N1.000
12:120713331:T:CI101T1.000
12:120713331:T:GI101S1.000
12:120713334:G:CR102P1.000
12:120713358:T:AL110H1.000
12:120713358:T:CL110P1.000
12:120713360:T:AF111I1.000
12:120713360:T:CF111L1.000
12:120713360:T:GF111V1.000

dbSNP variants (sampled 300 via entrez): RS1000043490 (12:120712296 A>G), RS1000254956 (12:120715500 T>A), RS1000500753 (12:120718215 T>G), RS1000614 (12:120711137 C>G,T), RS1000615 (12:120711372 C>A,T), RS1000858810 (12:120717120 G>T), RS1001006806 (12:120722776 C>G), RS1001090512 (12:120716290 T>C), RS1001530881 (12:120714293 T>C), RS1001565429 (12:120712869 AGTTGGCAAACTAAC>A), RS1001608994 (12:120713729 C>G), RS1002014842 (12:120714615 G>A), RS1002133046 (12:120720986 A>G), RS1003237251 (12:120721887 G>A,T), RS1003493853 (12:120712190 T>G)

Disease associations

OMIM: gene MIM:620513 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

12 associations (top):

StudyTraitp-value
GCST004602_163Mean corpuscular volume6.000000e-45
GCST004630_188Mean corpuscular hemoglobin3.000000e-39
GCST006249_30Serum metabolite levels4.000000e-177
GCST006804_116Red cell distribution width7.000000e-17
GCST012020_372Serum metabolite levels1.000000e-31
GCST012353_6Serum metabolite concentrations in chronic kidney disease5.000000e-14
GCST90002390_74Mean corpuscular hemoglobin9.000000e-119
GCST90002392_394Mean corpuscular volume4.000000e-154
GCST90002396_538Mean reticulocyte volume6.000000e-139
GCST90002397_219Mean spheric corpuscular volume9.000000e-116
GCST90002403_461Red blood cell count8.000000e-63
GCST90002404_146Red cell distribution width2.000000e-41

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0004527mean corpuscular hemoglobin
EFO:0009188Red cell distribution width
EFO:0010701mean reticulocyte volume
EFO:0004305erythrocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

22 total (human), top 22 by PubMed support.

ChemicalActions (top 5)PubMed papers
triphenyl phosphateaffects expression1
arseniteaffects binding, decreases reaction1
sodium arsenitedecreases expression1
butyraldehydedecreases expression1
di-n-butylphosphoric acidaffects expression1
2-palmitoylglycerolincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideincreases expression, affects cotreatment1
clothianidinincreases expression1
LDN 193189affects cotreatment, increases expression1
Leflunomidedecreases expression1
Air Pollutantsdecreases expression1
Cadmiumincreases abundance, increases expression1
Diurondecreases expression1
Ethyl Methanesulfonateincreases expression1
Tetrachlorodibenzodioxinaffects expression1
Thiramdecreases expression1
Valproic Acidaffects expression1
Cyclosporinedecreases expression1
Aflatoxin B1increases methylation1
Cadmium Chlorideincreases abundance, increases expression1
Okadaic Aciddecreases expression1
Copper Sulfatedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.